ALT Q1 2023 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,000-34.4% YoY

Gross Profit

$21,000100.0% margin

Operating Income

-$22M-103614.3% margin

Net Income

-$20M-95590.5% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+119.1%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$187M

Total Liabilities

$19M

Stockholders' Equity

$168M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,000	$32,000	-34.4%
Gross Profit	$21,000	-$17M	+100.1%
Operating Income	-$22M	-$19M	-11.6%
Net Income	-$20M	-$19M	-3.3%